Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study

Posted on by

Lancet Infectious Diseases
Jul 2019 Volume 19Number 7p671-788, e225-e258
http://www.thelancet.com/journals/laninf/issue/current

 

Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study
Joke Bilcke, et al.